Literature DB >> 17610948

A naturally derived, cytocompatible, and architecturally optimized scaffold for tendon and ligament regeneration.

Patrick W Whitlock1, Thomas L Smith, Gary G Poehling, Jeffrey S Shilt, Mark Van Dyke.   

Abstract

Tissue-engineered tendon scaffolds have the potential to significantly improve the treatment of tendon and ligament injuries, especially those associated with tumors, trauma, and congenital deficiencies where autograft or allograft tissue might not be available in sufficient quantity for reconstruction. In this study, a tendon scaffold was produced that: (1) has decreased/absent cellular material histologically, as well as significantly decreased DNA content in comparison with the material it is derived from-fresh-frozen flexor digitorum profundus tendon; (2) is cytocompatible in vitro; (3) has been modified to produce increased pore size and porosity; (4) retains 76-78% of the tensile properties of the material it is derived from; (5) is readily infiltrated by fibroblast-like, mononuclear host cells; and (6) does not exhibit a host-cell-mediated foreign-body immune response after implantation in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610948     DOI: 10.1016/j.biomaterials.2007.05.029

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  31 in total

1.  Biodegradable synthetic scaffolds for tendon regeneration.

Authors:  Ernesto Reverchon; Lucia Baldino; Stefano Cardea; Iolanda De Marco
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

2.  Human fascia lata ECM scaffold augmented with immobilized hyaluronan: inflammatory response and remodeling in the canine body wall and shoulder implantation sites.

Authors:  Diane R Leigh; Myung-Sun Kim; David Kovacevic; Andrew R Baker; Carmela D Tan; Anthony Calabro; Kathleen A Derwin
Journal:  J Biomater Sci Polym Ed       Date:  2014-11-17       Impact factor: 3.517

3.  Success and efficiency of cell seeding in Avian Tendon Xenografts - A promising alternative for tendon and ligament reconstruction.

Authors:  Simon Thönnes; Peter Shelton; Daniel N Bracey; Mark Van Dyke; Patrick Whitlock; Thomas L Smith; Arash Moghaddam; Christopher Tuohy
Journal:  J Orthop       Date:  2019-09-12

4.  Implantation of a novel biologic and hybridized tissue engineered bioimplant in large tendon defect: an in vivo investigation.

Authors:  Ahmad Oryan; Ali Moshiri; Abdolhamid Meimandi Parizi; Nicola Maffulli
Journal:  Tissue Eng Part A       Date:  2013-10-12       Impact factor: 3.845

Review 5.  Extracellular matrix-based biomaterial scaffolds and the host response.

Authors:  Joseph M Aamodt; David W Grainger
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

6.  Characterization of and host response to tyramine substituted-hyaluronan enriched fascia extracellular matrix.

Authors:  Likang Chin; Anthony Calabro; E Rene Rodriguez; Carmela D Tan; Esteban Walker; Kathleen A Derwin
Journal:  J Mater Sci Mater Med       Date:  2011-05-07       Impact factor: 3.896

7.  Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs.

Authors:  Catherine K Kuo; Joseph E Marturano; Rocky S Tuan
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-08-20

8.  Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds.

Authors:  Allison J Beattie; Thomas W Gilbert; Juan Pablo Guyot; Adolph J Yates; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

9.  Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds.

Authors:  Jolene E Valentin; Ann M Stewart-Akers; Thomas W Gilbert; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

10.  Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery.

Authors:  Patrick Basile; Tulin Dadali; Justin Jacobson; Sys Hasslund; Michael Ulrich-Vinther; Kjeld Søballe; Yasuhiko Nishio; M Hicham Drissi; Howard N Langstein; David J Mitten; Regis J O'Keefe; Edward M Schwarz; Hani A Awad
Journal:  Mol Ther       Date:  2008-01-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.